11
Views
11
CrossRef citations to date
0
Altmetric
Original Article

Renal Anaemia Treatment with Recombinant Human Erythropoietin Increases Cardiac Output in Patients with Ischaemic Heart Disease

, , &
Pages 115-120 | Received 30 Jul 1994, Accepted 29 Mar 1995, Published online: 15 Feb 2010

REFERENCES

  • Abdulhadi MH, Fouad-Tarazi FM, Thomas T, Bravo EL, Paganini EP. The haemodynamic effects of correction of anaemia in haemodialysis patients using recombinant human erythropoietin. Nephrol Dial Transplant 1990; (Suppl 1): 102–108.
  • Buckner FS, Eschbach JW, Haley NR, Davidson RC, Adamson JW. Hypertension following erythropoietin therapy in anemic hemodialysis patients. Am J Hypertens 1990; 3: 947–955.
  • Cannella G, LaCanna G, Sandrini M, Gaggiotti M, Nordio G, Movilli E, Maiorca R. Renormalization of high cardiac output and left ventricular size following long-term recombinant human erythropoietin treatment of anemic dialyzed uremic patients. Clin Nephrol 1990; 34: 272–278.
  • Crystal GJ, Salem MR. Myocardial oxygen consumption and segmental shortening during selective coronary hemodilution in dogs. Anesth Analg 1988; 67: 500–508.
  • Gisselsson L, Rosberg B, Ericsson M. Myocardial blood flow, oxygen uptake and carbon-dioxide release of the human heart during hemodilution. Acta Anesth Scand 1982; 26: 589–591.
  • Gould KL. Agreement on the accuracy of thallium stress testing [editorial; comment]. J Am Coll Cardiol 1990; 16: 1022–1023.
  • Hori K, Onoyama K, Iseki K, Fujimi S, Fujishima M. Hemodynamic and volume changes by recombinant human erythropoietin (rhEPO) in the treatment of anemic hemodialysis patients. Clin Nephrol 1990; 33: 293–298.
  • Ikram H, Lynn KL, Bailey RR, Little PJ. Cardiovascular changes in chronic hemodialysis patients. Kidney Int 1983; 24: 371–376.
  • Iskandrian AS. SPECT thallium imaging in the diagnosis of myocardial ischemia [editorial; comment]. J Am Coll Cardiol 1990; 16: 1024–1025.
  • Kamata K, Marumo F, Onoyama K. Hemodynamic mechanism of the elevation in blood pressure following the improvement of anemia with recombinant human erythropoietin. Japanese Circulation Journal 1991; 55: 649–656.
  • London GM, Zins B, Pannier B, Naret C, Berthelot J, Jacquot C, Safar M, Drueke TB. Vascular changes in hemodialysis patients in response to recombinant human erythropoietin. Kidney Int 1989; 36: 878–882.
  • Mannting F. A new method for quantification of pulmonary thallium uptake in myocardial SPECT studies. Eur J Nucl Med 1990; 16: 213–222.
  • Martinez VA, Bardaji A, Garcia C, Ridao C, Richart C, Oliver JA. Long-term myocardial effects of correction of anemia with recombinant human erythropoietin in aged patients on hemodialysis. Am J Kidney Dis 1992; 19: 353–357.
  • Mayer G, Cada EM, Watzinger U, Barnas U, Graf H. Hemodynamic effects of partial correction of chronic anemia by recombinant human erythropoietin in patients on dialysis. Am J Kidney Dis 1991; 17: 286–289.
  • Mehlsen J, Bonde J, Stadeager C, Rehling M, Tangö M, Tarp-Jensen J. Reliability of impedance cardiography in measuring central haemodynamics. Clinical Physiology 1991; 11: 579–588.
  • Neff MS, Kim KE, Persoff M, Onesti G, Swartz C. Hemodynamics of uremic anemia. Circulation 1971; 43: 876–883.
  • Nonnast-Daniel B, Deschodt G, Brunkhorst R, Creutzig A, Bahlmann J, Shaldon S, Koch KM. Long-term effects of treatment with recombinant human erythropoietin on haemodynamics and tissue oxygenation in patients with renal anaemia. Nephrol Dial Transplant 1990; 5: 444–448.
  • Pascual J, Teruel JL, Marcen R, Liano F, Moya JL, Jimenez M, Ortuno J. Hemodynamic and cardiac effects of erythropoietin in patients on regular dialysis. Int J Artif Organs 1992; 15: 349–353.
  • Pickett BR, Buell JC. Validity of cardiac output measurement by computer-averaged impedance cardiography, and comparison with simultaneous thermodilution determinations. Am J Cardiol 1992; 69: 1354–1358.
  • Satoh K, Masuda T, Ikeda Y, Kurokawa S, Kamata K, Kikawada R, Takamoto T, Marumo F. Hemodynamic changes by recombinant erythropoietin therapy in hemodialyzed patients. Hypertension 1990; 15: 262–266.
  • Schwartz AB, Prior JE, Mintz GS, Kim KE, Kahn SB. Cardiovascular hemodynamic effects of correction of anemia of chronic renal failure with recombinant human erythropoietin. Transplant Proc 1991; 23: 1827–1830.
  • Sramek B. Hemodynamic and pump-performance monitoring by electrical bioimpedance. Problems in Respiratory Care 1989; 2: 274–290.
  • Teruel JL, Pascual J, Jimenez M, Liano F, Rivera M, Martinez J, Moya JL, Ortuno J. Hemodynamic changes in hemodialyzed patients during treatment with recombinant human erythropoietin. Nephron 1991; 58: 135–137.
  • Thomas SH. Impedance cardiography using the Sramek-Bernstein method: accuracy and variability at rest and during exercise. Br J Clin Pharmacol 1992; 34: 467–476.
  • Vara-Thorbeck R, Guerrero-Fernandez Marcote JA. Hemodynamic response of elderly patients undergoing major surgery under moderate normovolemic hemodilution. Eur Surg Res 1985; 17: 372–376.
  • Verbeelen D, Bossuyt A, Smitz J, Herman A, Dratwa M, Jonckheer MH. Hemodynamics of patients with renal failure treated with recombinant human erythropoietin. Clin Nephrol 1989; 31: 6–11.
  • Vincenti F, Amend WJ, Abele J, Feduska NJ, Salvatierro O. The role of hypertension in hemodialysis-associated atherosclerosis. Am J Med 1980; 68: 363–369.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.